PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma
Recently, increasing evidence has indicated that platelet-activating factor acetylhydrolase 1b catalytic subunit 3 (PAFAH1B3) plays an important role in several cancers. However, its role in lung adenocarcinoma (LUAD) has not been reported until now.